• 1
    Blaese RM, Culver K, Anderson WF. The ADA human gene therapy clinical protocol. Hum Gen Ther 1990; 1: 33162.
  • 2
    Sikora K. Genes, dreams and cancer. Br Med J 1994; 308: 121722.
  • 3
    Wu GY, Wu CH. Delivery systems for gene therapy. Biotherapeutics 1991; 3: 8795.
  • 4
    Ali M, Lemoine NR, Ring CJA. The use of DNA viruses as vectors for gene therapy. Gene Therapy 1994; 1: 36784.
  • 5
    Sutter G, Moss B. Non-replicating vaccinia virus vector efficiently expresses recombinant genes. Proc Natl Acad Sci USA 1992; 89: 1084751.
  • 6
    Vtemink K, Valet L, Mareel M et al. Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell 1991; 66: 10719.
  • 7
    Saison-Behomoaras T, Tocque B, Rey I et al. Short modified antisense oligodeoxynucleotides directed against HRAS point mutation induce selective cleavage of the mRNA and inhibit T24 cell proliferation. EMBO J 1991; 10: 111118.
  • 8
    McDonell T, Troncodo P, Bridbay SM et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen independent prostate cancer. Cancer Res 1992; 52: 69404.
  • 9
    Cai DW, Mukhopadhyay T, Liu T et al. Stable expression of the wild type p53 gene in human lung cancer cells after retroviral-mediated gene transfer. Hum Gene Ther 1993; 4: 101724.
  • 10
    Roth J, Mukhopadhyay T, Zhang WW et al. Gene replacement strategies for the prevention and therapy of cancer. Eur J Cancer 1994; 30: 20327.
  • 11
    Harris J, Guttierez A, Lemoine N et al. Gene therapy for cancer using tumour-specific prodrug activation. Gene Therapy 1994; 1: 1749.
  • 12
    Huber BE, Austin E, Richards CA et al. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumour cells transduced with the cytosine deaminase gene. Proc Natl Acad Sci USA 1994; 71: 83026.
  • 13
    Di Maoi JM, Clary B, Via D et al. Directed enzyme prodrug gene therapy for pancreatic cancer in vivo. Surgery 1994; 116: 20513.
  • 14
    Huber BE, Richards CD, Krenitsky TA. Retroviral-mediated gene transfer for the treatment if hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 1991; 88: 803943.
  • 15
    Rosenberg SA, Aebersold P, Cornetta K et al. Gene transfer into humans: immunotherapy of patients with advanced melanoma using TIL cells modified by retroviral gene transduction. New Eng J Med 1991; 323: 5705.
  • 16
    Gansbacher B, Bannerji R, Daniels B et al. Retroviral mediated gamma interferon gene transfer into tumour cells generates potent and long-lasting antitumour immunity. Cancer Res 1990; 50: 78208.
  • 17
    Townsend SE, Allison JP. Tumour rejection after direct co-stimulation of CD8 + T cells by B7-transfected melanoma cells. Science 1993; 259: 36870.
  • 18
    Conroy RM, Lobuglio A, Kantor J et al. Immune responses to a CEA polynucleotide vaccine. Cancer Res 1994; 54: 11648.
  • 19
    Hrouda D, Dalgleish A. Gene therapy for prostate cancer. Gene Therapy 1996; 3: 84552.
  • 20
    Committee on the Ethics of Gene Therapy. Report of the Committee on the Ethics of Gene Therapy. London: HMSO, 1992.